Skip to content

Investigation on how to prevent and treat type 2 diabetes by the tolerance to adiposity

Investigation on how to prevent and treat type 2 diabetes by the tolerance to adiposity - Investigation on the tolerance to adiposity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000017735
Enrollment
30
Registered
2015-05-29
Start date
2014-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

None listed

Sponsors

Toho University Omori Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who are suffered from fatty liver, are suspected to be nonalcoholic fatty liver disease, and need liver biopsy exam will be qualified for this study.

Exclusion criteria

Exclusion criteria: Subjects who are suffered from heart disease, stroke, cancer, cirrhosis,infection, or collagen disease are excluded.

Design outcomes

Primary

MeasureTime frame
Life style, gene, and fat disposition which make it possible to be tolerant to fat

Countries

Japan

Contacts

Public ContactNaoki Kumashiro

Toho University Omori Medical Center Division of Diabetes, Metabolism, and Endocrinology

naoki.kumashiro@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026